CMS has published a fact sheet (MLN3191598) providing comprehensive guidance on Intravenous Immune Globulin (IVIG) items and services. The document outlines coverage parameters, supplier eligibility criteria, and specific billing and coding requirements, including information on claims edits. This release serves as an informational resource for healthcare providers participating in Medicare.

Healthcare providers who bill for IVIG items and services should review this fact sheet to ensure compliance with Medicare coverage, eligibility, and billing regulations. Understanding the outlined coding requirements and claims edits is crucial for accurate claim submission and to avoid potential claim rejections or audits. No specific compliance deadline is mentioned, implying adherence to current billing practices while incorporating the new guidance.